Evidence mapPaperPMID 41606728Full record

ArticleBMC endocrine disorders2026

The association between cardiometabolic index and hypertension-diabetes comorbidity among adults aged 45 and older: evidence from two national databases.

Dong Yang, Jialiang Huang, Lincheng Duan, Zeping Chen, Yue Feng

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dong YangChengdu University of Traditional Chinese Medicine, Chengdu, China.
Jialiang HuangChengdu University of Traditional Chinese Medicine, Chengdu, China.
Lincheng DuanChengdu University of Traditional Chinese Medicine, Chengdu, China.
Zeping ChenChengdu University of Traditional Chinese Medicine, Chengdu, China.
Yue FengChengdu University of Traditional Chinese Medicine, Chengdu, China. fengyue714@163.com.

Funding

National Natural Science Foundation of China 82575249Sichuan Provincial Natural Science Foundation 25NSFSC2297
6 · The paper itself

Abstract

backgroundThis study utilizes data from two principal sources: the National Health and Nutrition Examination Survey (NHANES) conducted in the United States from 1999 to 2020 and the China Health and Retirement Longitudinal Study (CHARLS) from 2011. This study examines the association between cardiometabolic index (CMI) and hypertension–diabetes comorbidity among individuals aged 45 years and older in the general population. Clarifying this relationship is important for developing effective prevention and management strategies for hypertension and diabetes in middle-aged and older individuals.

methodsThis study utilized data from NHANES (1999–2020) and CHARLS (2011) to conduct a cross-sectional analysis. The study population comprised adults aged 45 years and older from the general population. The cardiometabolic index (CMI) was calculated using the waist-to-height ratio and the triglycerides-to-high-density lipoprotein cholesterol (HDL-C) ratio. Weighted multivariate logistic regression analyses were employed to assess the association between LnCMI and the likelihood of hypertension–diabetes comorbidity, while adjusting for potential confounders. Subgroup analyses, restricted cubic spline (RCS), interaction tests, threshold effect analyses, and sensitivity analyses were performed.

resultsAssociations were observed in both databases between LnCMI and the prevalence of hypertension–diabetes comorbidity in adults aged 45 years and older. In CHARLS, the fully adjusted logistic regression model showed a positive association between higher LnCMI and hypertension–diabetes comorbidity (OR = 1.760, 95% CI: 1.574–1.964), with a threshold value of 0.121. In ROC analyses, CMI showed the highest discriminative performance among the tested indices in CHARLS (AUC = 0.739). In NHANES, the survey-weighted fully adjusted logistic regression model also showed a positive association between higher LnCMI and the odds of hypertension–diabetes comorbidity (OR = 1.995, 95% CI: 1.794–2.218), with a threshold value of 0.286. Subgroup analyses suggested that sex and smoking status modified the association between LnCMI and hypertension–diabetes comorbidity.

conclusionsIn these cross-sectional surveys, LnCMI was associated with hypertension–diabetes comorbidity prevalence and may be a useful marker for population prevalence stratification in China and the United States. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Diabetes MellitusHypertensionAgedChinaComorbidityCross-Sectional StudiesDatabases, FactualFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedNutrition SurveysPrevalencePrognosisCardiometabolic indexCHARLSDiabetesHypertensionNHANES

Identifiers

PMID41606728
PMCPMC12922348

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.